Daniel Jamieson, Biorelate
Daniel Jamieson
CEO
Biorelate

Dr Daniel Jamieson founded Biorelate after supporting the successful identification of drug repurposing opportunities with Pfizer in a groundbreaking project to curate the first-ever knowledge graph to represent the pain interactome. Biorelate is now the leading provider of contextualised data and cause-and-effect data insights, curated via best-in-class large language models, AI and NLP; Daniel’s focus remains on helping pioneering biopharma companies in their mission to develop life-saving innovations.